[Patient-related rejection of nasal IPPV therapy. Patients, reasons, follow-up].
METHODS
We retrospectively analysed the course of 33 patients who had rejected nasal IPPV-therapy (1988 to February 1996).


RESULTS
The death-rate was higher (48%) compared to nasal IPPV patients in the same time (18%). The patients were divided in 3 main diagnostic groups (COPD, restrictive thoracic wall, neuromuscle disease). We observed the highest death-rate in COPD patients (66%) and the lowest death-rate in the group with scoliosis or chest wall disease (23%). This is the same result tendencially as in patients with nasal IPPV (mortality-rate COPD 66%, restrictive chest wall 6%).
Pahnke
J
J
Pneumologische Klinik im Zentralkrankenhaus Gauting.
Bullemer
F
F
Heindl
S
S
Karg
O
O
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002423:Cause of Death; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007385:Intermittent Positive-Pressure Ventilation / Q000523:psychology*; D008173:Lung Diseases, Obstructive / Q000401:mortality / Q000523:psychology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012131:Respiratory Insufficiency / Q000401:mortality / Q000523:psychology* / Q000628:therapy; D015996:Survival Rate; D016312:Treatment Refusal
Patientenbedingte Ablehnung der nasalen IPPV-Therapie. Patienten, Gründe, Verlauf.